EMERGENCY RESUSCITATION RESEARCH
$83
Revenue
5
Filings
Latest Financial Summary
| Fiscal Year | Revenue | Expenses | Net Assets | Contributions |
|---|---|---|---|---|
| FY 2025 | $83 | $996 | $-2K | $0 |
Key Officers
M
MARSHALL B SEGAL MD
DIRECTOR, PRES
D
DAVID BEISER MD
DIRECTOR, VP
T
TERRY VANDEN HOEK MD
DIRECTOR, SEC
Filing History
Similar Organizations
Medical Research · IL
NEUROFIBROMATOSIS INC
WHEATON
